Pictet Asset Management (UK)’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-255,000
Closed -$5.12M 903
2014
Q2
$5.12M Buy
255,000
+65,200
+34% +$1.5M 0.02% 553
2014
Q1
$5.16M Buy
189,800
+10,100
+6% +$268K 0.03% 524
2013
Q4
$3.73M Sell
179,700
-75,700
-30% -$1.43M 0.02% 600
2013
Q3
$4.66M Sell
255,400
-123,900
-33% -$2.24M 0.03% 526
2013
Q2
$6.31M Buy
+379,300
New +$6.06M 0.04% 425

Other funds holding AUXL

Pictet Asset Management (UK)'s AUXL Position: Q3 2014 in Review

Pictet Asset Management (UK) sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 255,000 shares — an estimated $5.12M sold.

Pictet Asset Management (UK) first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $6.31M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Pictet Asset Management (UK) reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 255,000 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $5.12M.
  • Pictet Asset Management (UK) first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Pictet Asset Management (UK)'s AUXILIUM PHARAMCEUTICALS INC position peaked at $6.31M in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2014, filed 12 Nov 2014.